LSIF has invested in SenzaGen

We are delighted to invest in SenzaGen in a directed issue. We find the idea of replacing testing on animal with the SenzaGen technological platform to be a fantastic alternative, which we are happy to support.
we also believe it to be a promising investment. We believe SenzaGen is well on track towards profitability with competent management, a clear vision and with getting traction on the sales side. We look forward to follow SenzaGen in the years to come. See the SenzaGen press release here